Developed and implemented strategic customer business plans for assigned Mental Health Institutions throughout Texas and Louisiana to create product access and increase local market sales. Coordinated and lead the tactical implementation of the customer business plan with Area Business Leads and Sales Specialists to successfully drive pull-through within assigned accounts. Worked closely with key opinion leaders within mental health systems to drive push through of antipsychotic sales and messaging to affiliate Community Mental Health Centers. Through application of strategic account management skills, successfully developed long-term relationships with key decision-makers within State Hospitals, Private Hospitals, State Medicaid, and Community Mental Health Centers throughout Texas and Louisiana. Targeting key influencers within mental health accounts and associated networks, successfully created brand and disease advocacy that increased sales of antipsychotics within the accounts and their extended account networks.Key Achievements:-2012 Business Performance Award

Increased sales performance of Pfizer products by creating and maintaining access within targeted managed care accounts including Health Plans, Self-funded Employers, Medical Groups and Healthcare Coalitions in Texas. Leveraged consultative selling skills and interpersonal relationships with customer base to develop and implement value-added programs to develop and expand markets for Pfizer products. Lead cross-functional team of National Account Managers, State Director and local District Business Managers to develop strategies and tactics to maximize product access opportunities and facilitate pull/push through projects to increase sales of Pfizer products.Key Achievements:Formulary Wins:-Orchestrated product support strategy with key product advocates and Chief Medical Officer to maintain PDL access for Lipitor despite the launch of generic competition to the marketplace with a large Medicare Part D plan. Protected $7 million in sales for Texas Region.-Maintained formulary access to Geodon by leveraging P&T member support, key opinion influencer support and by presenting the clinical case with the Pharmacy Department of Correctional Managed Care. Preserved product revenue of $970,000.-Secured early post-launch formulary approval for Chantix and Lyrica at large Houston Area Medical Group resulting in annual combined sales of over $2 million.-Resolved Lipitor contract issue with Medicare Part D Plan protecting $30 million in annual sales.-Developed, presented and sold the business case for smoking cessation benefits to an area Healthcare Benefits Broker resulting in preferred access to Chantix for over 2,000 employees at three self-funded employers in the fourth quarter of 2010 with an additional 50,000 forecasted for 2011.

Responsible for driving sales performance by creating and maintaining access to Pharmacia products within targeted managed care accounts including Aetna, BCBS of Texas, CIGNA, Humana, Kelsey-Seybold and United Healthcare. Collaborated with customer base to develop and implement value-added programs to develop and expand markets for Pharmacia products. Coordinated with National Account Managers, Regional and local District Management to develop strategies and tactics to maximize access opportunities and facilitate pull/push through projects to increase sales of Pharmacia products.Key Achievements:-Moved Celebrex from non-preferred to unrestricted preferred access on the BlueCross Blue Shield of Texas formulary by identifying key product advocates, leveraging contract strategies, and presenting clinical, safety and pharmacoeconomic data. Successful project resulted in moving Vioxx to non-preferred status and increased Celebrex COX2 market share from 50% in Q1 ’02 to 62% in Q3 ’02 (+24%).-2000 Platinum Club Award Winner

A senior level sales position responsible for development and implementation of marketing strategies to maximize access and sales of Pharmacia & Upjohn products in City/County Health Clinics and large medical group practices influenced heavily by managed care. Sales territory was accountable for annual sales in excess of $5 million.Key Achievements:-Influenced key opinion leaders and P&T members with clinical, safety and pharmacoeconomic data post-product launch to secure PDL approval for Vantin, Depo-Provera 150mg, Cleocin Vaginal Cream and Altace with Kelsey-Seybold Clinic and MacGregor Medical Association. Combined formulary wins contributed to a 192% territory gain for the year.-Increased sales of Depo-Provera to the City of Houston by $100,000, a 38% increase, in the first year calling on this account-Developed and sold the clinical and pharmacoeconomic case for Depo-Provera with key physicians of the Harris County Health Department resulting in incremental sales of $53,000.-Selected by senior management to develop and implement training for new recruits within the Southwest Region enabling Representatives to more effectively sell in the emerging managed care landscape. -Achieved Premier (Pharmacia & Upjohn’s highest sales award) for top 6% sales performance in 1998